Amneal Pharmaceuticals, Inc.
AMRX
$7.48
$0.060.81%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 68.49% | -101.61% | -49.70% | -1,219.93% | -2,176.69% |
| Total Depreciation and Amortization | 16.15% | 3.07% | -2.69% | -4.51% | -6.75% |
| Total Amortization of Deferred Charges | 466.79% | -38.97% | -62.15% | -86.01% | 121.46% |
| Total Other Non-Cash Items | -70.85% | -17.31% | -9.89% | 34.90% | 124.49% |
| Change in Net Operating Assets | -59.30% | 223.12% | 52.90% | -122.06% | 139.72% |
| Cash from Operations | -13.06% | 74.20% | 449.55% | -103.16% | 683.13% |
| Capital Expenditure | -90.50% | -37.16% | 3.86% | 11.75% | -2.84% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 96.98% | -260.00% | 34.78% | -2,769.82% | -- |
| Cash from Investing | 49.33% | -53.70% | 47.37% | -68.36% | -176.40% |
| Total Debt Issued | -100.00% | -100.00% | -100.00% | -40.00% | -- |
| Total Debt Repaid | 78.85% | -36.38% | -81.10% | 12.77% | -1,387.31% |
| Issuance of Common Stock | 251.16% | 51.23% | -- | -- | -- |
| Repurchase of Common Stock | -148.08% | -2.65% | -1,345.45% | -256.68% | -77.27% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 96.70% | 83.08% | 52.19% | 96.74% | -3,626.12% |
| Cash from Financing | 39.30% | -6.65% | -186.28% | -79.50% | -354.87% |
| Foreign Exchange rate Adjustments | -468.16% | 102.33% | 83.22% | -121.51% | 105.38% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,045.00% | 251.37% | 94.53% | -141.00% | 105.77% |